GRAIL is a healthcare company developing multi-cancer early-detection blood tests. Its Galleri test uses signals in blood to screen for many cancer types, making the company part of the wider computational biology and diagnostics landscape around large-scale health data.
Former members 1
Related organizations
Based on public sources. If accuracy is important, verify details using the links or references.
For corrections, updates, or requests to remove information, contact us.